RamiroGarzonMD
Hematology • Columbus, OHAssociate Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Garzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 12th Ave
1084 Brt
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-7526- Is this information wrong?
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2002 - 2005
Danbury HospitalResidency, Internal Medicine, 1999 - 2002
Universidad Nacional de CordobaClass of 1994
Certifications & Licensure
UT State Medical License 2022 - 2026
OH State Medical License 2005 - 2023
PA State Medical License 2002 - 2006
Clinical Trials
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease Start of enrollment: 2012 Feb 20
- AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
- Join now to see all
Publications & Presentations
PubMed
- CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model.Neidemire-Colley, L., Khanal, S., Braunreiter, K., Gao, Y., Kumar, R., Snyder, K., Weber, M., Surana, S., Toirov, O., Karunasiri, M., Duszynski, M., Chi, M., Malik, P....> ;Blood Advances. 2024 Feb 27
- 1 citationsPhase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani, Karilyn Larkin, James S Blachly, Mohamed A Badawi, Kasey L Hill, Kyle R Dzwigalski,...> ;Leukemia & Lymphoma. 2023 Dec 1
- Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma.Chinmayee Goda, Sofia Kolovich, Alexander Rudich, Malith Karunasiri, Rohan Kulkarni, Girish Rajgolikar, Lotus Neidemire-Colley, Satishkumar Singh, Anuvrat Sircar, Parv...> ;Experimental Hematology. 2023 Jul 1
- Join now to see all
Abstracts/Posters
- EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leuke...Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Long Noncoding RNAs: Novel Prognostic Marker in Older Patients with Acute LeukemiaDecember 15th, 2014- Inhibitors of Shuttle Molecule Show Promise in Acute LeukemiaJune 19th, 2012
Huntsman Cancer Institute Researchers Find Link Between Folic Acid and Blood Cell ProductionDecember 15th, 2023
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
